Welcome to APhA's Education Library


Click links below for more information

  • Can be sorted by Newest or By Title . (The titles are listed alphabetically.)
  • Goals / objectives of the course can be seen by clicking on the title
  • Enroll and/or purchase the course by clicking on Enroll Now or Add To Cart
  • Once purchased. the course will be found under My Training
  • TIP: Use the search engine, or scroll down to bottom and select 50 per page .
If you have registered for the APhA program through one of our licensed partners which is hosting the APhA Program - that Organization's coordinator will provide you with an enrollment code to gain access to the required course materials. You can redeem your enrollment code at My Training

APhA's Education Library

Found 132
Sort by
Home Study
Member Free
Non-Member $25.00

Managing Clinically Significant Drug Interactions in Patients with HIV and Comorbid Conditions

The objective of this activity is to review common drug interactions associated with the use of anti-retroviral (ARV) agents for treatment of HIV and comorbid conditions, and to provide pharmacists with guidance for managing potential interactions.
hiv drug interactions drug information
Home Study
Member Free
Non-Member $25.00

Hot Topics in Immunization

This review will describe recent changes in recommended immunization practices, including the introduction of new vaccines, and will explore other immunization issues of interest to pharmacists.
immunizations
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 4

In this review, eleven new therapeutic agents marketed in the United States in 2015 are considered: selexipag, cobimetinib, osimertinib, necitumumab, alectinib, insulin degludec, lesinurad, mepolizumab, brexpiprazole, cariprazine, and flibanserin.
new drugs drug information
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 3

This review covers 11 new therapeutic agents approved in the United States in 2015.
new drugs drug information
Home Study
Member Free
Non-Member $25.00

Expanding the Use of Naloxone to Treat Opioid Overdose

Pharmacists who are well informed about the use and regulatory framework for naloxone can help address barriers to naloxone access and reduce the public health burden of opioid overdose.
new drugs addiction pain management drug information
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 1

In this review, eight new therapeutic agents marketed in the United States in 2015 are considered: edoxaban, secukinumab, panobinostat, palbociclib, lenvatinib, dinutuximab, ceftazidime-avibactam, and isavuconazonium sulfate.
clinical patient care and services new drugs
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 2

In this review, eight new therapeutic agents marketed in the United States in 2015 are considered: ivabradine, cangrelor, deoxycholic acid, filgrastim-sndz, cholic acid, eluxadoline, parathyroid hormone, and lumacaftor-ivacaftor.
clinical patient care and services new drugs